听
听
Perimeter:
听
- Cell therapy, cell transplantation, stem cell听 therapy , translational medicine using cells
- Implantable tissue, scaffolds, hydrogels, organo茂ds,听 any tissue engineering
- Stem cells, IPS, MSC鈥檚, BM, Cord,鈥�
- Gene therapy, small molecules, mRNA , si RNA approaches for regenerative purpose
- Cell therapy for immunomodulatory /antiinflammation听 indications
- Cell product characterization: genomic, transcriptomic, proteomic, interactome
- Microparticles, microvesicles, exosomes
- Clinical translation, GMP development, first in man, tissue banks set up
听
Questions addressed:
Any relevant question aiming to translate regenerative medicine into clinical application, within the perimeter listed supra, but not exclusive.听 Reinforce the scientific support to clinical activities and vice versa
听
Potential impact:
IREC has a number of projects around this thematic; the aim is to increase visibility and attract talents and funding to develop听 regenerative medicine from bench to actual听 clinical application .听 Visibility also for third parties, including governmental and听 industrial partners as this activity must typically benefit from public private funding. International visibility and positioning of IREC in the field.
听